Vanguard Group Inc Gossamer Bio, Inc. Transaction History

Vanguard Group Inc

  • $6.44 Trillion
  • Q3 2025

A detailed history of Vanguard Group Inc transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 12,009,773 shares of GOSS stock, worth $32.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,009,773
Previous 11,410,792 5.25%
Holding current value
$32.5 Million
Previous $14 Million 125.04%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
BUY
$1.21 - $3.46 $724,767 - $2.07 Million
598,981 Added 5.25%
12,009,773 $31.6 Million
Q2 2025

Aug 11, 2025
BUY
$0.78 - $1.44 $1.03 Million - $1.91 Million
1,326,911 Added 13.16%
11,410,792 $14 Million
Q1 2025

May 09, 2025
BUY
$0.85 - $1.53 $42,272 - $76,089
49,732 Added 0.5%
10,083,881 $11.1 Million
Q4 2024

Feb 11, 2025
SELL
$0.66 - $1.07 $1.14 Million - $1.84 Million
-1,720,248 Reduced 14.63%
10,034,149 $9.03 Million
Q3 2024

Nov 13, 2024
SELL
$0.79 - $1.25 $4,624 - $7,317
-5,854 Reduced 0.05%
11,754,397 $11.6 Million
Q2 2024

Aug 13, 2024
SELL
$0.51 - $1.27 $1,801 - $4,486
-3,533 Reduced 0.03%
11,760,251 $10.6 Million
Q1 2024

May 10, 2024
BUY
$0.8 - $1.51 $102,520 - $193,506
128,150 Added 1.1%
11,763,784 $13.9 Million
Q4 2023

Feb 14, 2024
BUY
$0.48 - $1.08 $176,306 - $396,690
367,306 Added 3.26%
11,635,634 $10.6 Million
Q3 2023

Nov 14, 2023
BUY
$0.78 - $1.82 $6 Million - $14 Million
7,686,213 Added 214.57%
11,268,328 $9.35 Million
Q2 2023

Aug 14, 2023
SELL
$0.98 - $1.53 $2.91 Million - $4.54 Million
-2,967,636 Reduced 45.31%
3,582,115 $4.3 Million
Q1 2023

May 15, 2023
SELL
$0.96 - $2.92 $1.35 Million - $4.12 Million
-1,410,106 Reduced 17.72%
6,549,751 $8.25 Million
Q4 2022

Feb 10, 2023
BUY
$1.74 - $12.87 $1.07 Million - $7.9 Million
613,694 Added 8.35%
7,959,857 $17.3 Million
Q3 2022

Nov 14, 2022
BUY
$7.21 - $14.88 $10.8 Million - $22.2 Million
1,493,836 Added 25.53%
7,346,163 $88 Million
Q2 2022

Aug 12, 2022
BUY
$5.97 - $9.97 $1.18 Million - $1.97 Million
197,585 Added 3.49%
5,852,327 $49 Million
Q1 2022

May 13, 2022
BUY
$8.44 - $12.49 $567,868 - $840,364
67,283 Added 1.2%
5,654,742 $49.1 Million
Q4 2021

Feb 14, 2022
BUY
$10.12 - $14.07 $897,178 - $1.25 Million
88,654 Added 1.61%
5,587,459 $63.2 Million
Q3 2021

Nov 12, 2021
BUY
$7.25 - $13.23 $476,520 - $869,568
65,727 Added 1.21%
5,498,805 $69.1 Million
Q2 2021

Aug 13, 2021
BUY
$8.0 - $9.75 $43.5 Million - $53 Million
5,433,078 New
5,433,078 $44.1 Million

Others Institutions Holding GOSS

# of Institutions
179
Shares Held
163M
Call Options Held
8.11M
Put Options Held
211K
View Full List

About Gossamer Bio, Inc.

GOSS Quotes by TradingView
  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $255M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email